{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:31:43Z","timestamp":1765780303680,"version":"3.48.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570391"],"award-info":[{"award-number":["82570391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC0714"],"award-info":[{"award-number":["2025ZNSFSC0714"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cryoballoon ablation (CBA) is extensively utilized to treat paroxysmal atrial fibrillation (PAF). The IceMagicTM Cardiac CryoAblation System (CryoMST, MicroPort EP MedTech CO., Ltd, Shanghai, China) has recently been introduced.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the clinical efficiency and potential benefits of CryoMST in PAF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A propensity-score matched study compared 16 patients with PAF undergoing initial CBA with CryoMST against cohorts treated with Arctic Front Advance\u2122 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200948), radiofrequency ablation (RFA,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200948), and pulsed-field ablation (PFA,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916). Peri-procedural and 12-month outcome data were compared among the four groups to assess the efficacy and safety of the CryoMST.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The CryoMST cohort showed significant reductions in total procedure time [83.00 (Q1, Q3: 75.00, 89.25) vs. 102.00 (Q1, Q3: 85.00, 127.75)\u2005min], ablation time [20.00 (Q1, Q3: 18.74, 21.00) vs. 46.00 (Q1, Q3: 38.00, 55.75)\u2005min], fluoroscopy time [12.93 (Q1, Q3: 11.15, 16.96) vs. 17.85 (Q1, Q3: 12.35, 23.38)\u2005min], fluoroscopy dose [81.80 (Q1, Q3: 69.93, 96.03) vs. 200.00 (Q1, Q3: 134.75, 311.50)\u2005mGy], and contrast agent volume [16.00 (Q1, Q3: 11.00, 22.00) vs. 52.50 (Q1, Q3: 45.00, 57.00)\u2005mL] compared to the Arctic Front Advance\u2122 group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). CryoMST accurately predicted pulmonary vein occlusion, showing high concordance with pulmonary vein angiograph (sensitivity 89.3%, specificity 100.0%, Kappa value\u2009=\u20090.87,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). At 12-month follow-up, rates of arrhythmia recurrence and complications did not differ among the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The CryoMST system demonstrates excellent diagnostic accuracy for pulmonary vein occlusion, obviating the need for routine venography. It significantly reduces procedure time, radiation exposure, and contrast use compared to conventional CBA, while maintaining comparable 12-month efficacy and safety to established ablation modalities for PAF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1703472","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:27:57Z","timestamp":1765780077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the novel multi-points surface thermometry cryoballoon in the treatment of paroxysmal atrial fibrillation"],"prefix":"10.3389","volume":"12","author":[{"given":"Lu","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruikun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.hrthm.2024.03.017","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"21","author":"Tzeis","year":"2024","journal-title":"Heart Rhythm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/europace\/euz155","article-title":"Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation","volume":"21","author":"Hoffmann","year":"2019","journal-title":"Europace"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.hrthm.2015.03.021","article-title":"Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures","volume":"12","author":"Su","year":"2015","journal-title":"Heart Rhythm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1161\/01.CIR.0000146952.49223.11","article-title":"Radiation exposure during catheter ablation of atrial fibrillation","volume":"110","author":"Lickfett","year":"2004","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"741018","DOI":"10.1155\/2014\/872574","article-title":"Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention","volume":"2014","author":"Andreucci","year":"2014","journal-title":"BioMed Res Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1540-8167.2009.01524.x","article-title":"Cryoballoon pulmonary vein isolation guided by transesophageal echocardiography: novel aspects on an emerging ablation technique","volume":"20","author":"Sikl\u00f3dy","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/joa3.12679","article-title":"Transesophageal echocardiography guided transseptal puncture and nadir temperatures in cryoballoon pulmonary vein isolation","volume":"38","author":"Blockhaus","year":"2022","journal-title":"J Arrhythm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"euad086","DOI":"10.1093\/europace\/euad086","article-title":"Safety and efficacy of intracardiac echocardiography-guided zero-fluoroscopic cryoballoon ablation for atrial fibrillation: a prospective randomized controlled trial","volume":"25","author":"Ahn","year":"2023","journal-title":"Europace"},{"key":"B9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pace.14910","article-title":"Incidence of cryoballoon expansion dislodgement during pulmonary vein isolation-an underappreciated frequent cause of incomplete isolation","volume":"47","author":"Liao","year":"2024","journal-title":"Pacing Clin Electrophysiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hrthm.2017.05.004","article-title":"Novel dyeless and fluoro-less approach to cryoballoon pulmonary vein occlusion assessment","volume":"14","author":"Avitall","year":"2017","journal-title":"Heart Rhythm"},{"key":"B11","doi-asserted-by":"publisher","first-page":"22945","DOI":"10.1038\/s41598-023-49475-6","article-title":"Feasibility study of cryoballoon ablation for atrial fibrillation with KODEX-EPD: a single center experience","volume":"13","author":"Wubulikasimu","year":"2023","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/jcdd10100427","article-title":"Accuracy of the injection-based occlusion tool utilizing saline and glucose solution in cryoballoon ablation guided by a novel dielectric imaging system","volume":"10","author":"Mo","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"euae134","DOI":"10.1093\/europace\/euae134","article-title":"State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective","volume":"26","author":"Chun","year":"2024","journal-title":"Europace"},{"key":"B14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","article-title":"Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II","volume":"7","author":"Reddy","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14779072.2025.2569402","article-title":"Alternative options to thermal ablation for atrial fibrillation: the role of pulsed field ablation in reducing complications and maintaining efficacy","volume":"23","author":"Zito","year":"2025","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","article-title":"Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study","volume":"30","author":"Ekanem","year":"2024","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.hrthm.2015.10.033","article-title":"Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation","volume":"13","author":"Aryana","year":"2016","journal-title":"Heart Rhythm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/pace.13230","article-title":"Pulmonary vein isolation with real-time pulmonary vein potential recording using second-generation cryoballoon: procedural and biophysical predictors of acute pulmonary vein reconnection","volume":"41","author":"Wei","year":"2018","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1703472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:27:58Z","timestamp":1765780078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1703472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":18,"alternative-id":["10.3389\/fcvm.2025.1703472"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1703472","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1703472"}}